Clinical Trials Update: Dec. 15, 2010
Anti-Nicotine Vaccine (Smoking Cessation) Depression Cancer-Related Pain
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Anti-Nicotine Vaccine (Smoking Cessation)
This study will evaluate how an anti-nicotine vaccine. It's designed to produce antibodies that absorb nicotine in your blood, reducing nicotine levels in your brain and helping you to quit smoking.
The research site is in Winston-Salem, N.C.
This study will evaluate an investigational drug as an add-on treatment to an approved antidepressant. Candidates must be aged 18 to 65 and diagnosed with major depressive disorder.
The research site is in Atlanta, Ga.
This study seeks people with cancer-related pain. If you qualify, you may receive study-related medical evaluations at no cost, and compensation for time and travel.
The research site is in Laguna Hills, Calif.
Copyright 2010 ClinicalConnection.com. All rights reserved.